On September 4, 2025, the Office of the People's Government of Songjiang District, Shanghai held the 2024-2025 Songjiang District Government Quality Award Ceremony. Dunwill Medical has won the Songjiang District Quality Innovation Award for its quality management model of "starting with the end and transforming original biological markers into 1-2-3-4".

The District Government Quality Award is the highest quality honor award established by the Songjiang District People's Government. It is selected every two years to motivate organizations and individuals who have achieved outstanding performance in quality work in the district, guide various industries to improve quality management, pursue excellent performance, and fully play the dual driving role of quality and innovation in economic and social development. A total of 14 organizations and 1 individual were awarded this honor this time.

As a globally leading integrated whole process company for the research, development, and transformation of original biomarkers, Dunwill Medical Station is at the height of systems biology, using multiple omics technologies to work with clinical experts to study the mechanisms of complex disease occurrence and development from the "spatiotemporal dimension", promoting the formation of original clinical grade IVD products with independent intellectual property rights.

After years of accumulation and development, the company has successfully established a Dunwill cultural system of "people-oriented, continuous learning, and value co creation", committed to leading the excellent development of the enterprise with original research biomarkers. At the same time, the company has built multiple omics technology platforms and continuously consolidated its technological leading advantage in the transformation of original research biomarker products with "microRNA" as the core. With precise market positioning, the company has successfully created a commercial closed loop of "medical research, production, and sales", effectively promoting the efficient transformation of original research and innovation achievements. At present, the company has launched multiple original products, such as the world's first three type molecular diagnostic product for liver cancer - 7 microRNA testing kits (miRNA7), which fills the gap in the early diagnosis of liver cancer; In addition, the company has also launched products such as glycated albumin detection kits that break through foreign technological barriers.

Winning the Songjiang District Quality Innovation Award this time is not only a high recognition of Dunwill Medical's innovative achievements in quality management, but also injects new impetus into the company's sustained and outstanding development. Looking ahead to the future, the company will take this as a new starting point, continuously improve its quality management level, launch more original clinical grade IVD products, actively promote the high-quality development of precision diagnosis and treatment, and help achieve the strategic goal of "Healthy China" as soon as possible.